• CEO of telepsychiatry platform Cerebral, Kyle Robertson, has been asked to step down after being voted out by the company’s board. Robertson was not present for the vote and claims this decision to be illegal. 

<ul><li>This change in management comes after recent events where Cerebral investors pushed to have Robertson dismissed . This in turn was due to the recent string of events that resulted in the company stopping new and existing prescriptions of controlled substances and investigations being launched into the activities of the company by the Drug Enforcement Agency and the Department of Justice.</ul>

<ul><li>David Mou, the company’s president and chief medical officer (CMO), will take over as CEO, effective immediately. Mou had accepted the position of president earlier this month . Robertson claims that Mou had encouraged the prescribing practices of the company in a memo reviewed by the Wall Street Journal.</ul>

• Filling the position of president will be Jessica Muse who was previously serving as the chief operating officer (COO). Additionally, the board has added Thomas Insel, former director of the National Institute of Mental Health and clinical advisor to the company, as its newest member.